Abstract: A subsea control bundle umbilical comprises a carrier pipe, a bundle of elongate functional elements being tubes and/or cables that extend longitudinally within the carrier pipe, and spacers spaced apart longitudinally along the bundle. The spacers support the functional elements of the bundle and are movable longitudinally relative to the carrier pipe upon insertion during assembly, and also during installation of the umbilical and in use. As the umbilical does not convey production hydrocarbons flowing from a subsea well, any tubes within the carrier pipe have an inner diameter of no more than 70 mm. Any such tubes contain only a control fluid or a service fluid for supporting production of hydrocarbons. Each spacer comprises a stack of blocks and an opening that extends along a longitudinal axis through the spacer at an interface between abutting blocks of the stack. Each opening receives a respective elongate functional element of the umbilical.

Abstract: A convertible seating system for a marine vessel has a leaning post and a reversible seat having a first seat side and a second seat side which is transversely oriented to the first seat side. The reversible seat is coupled to the leaning post and movable into and between a forward seating position located above the leaning post and a rearward seating position located adjacent to the rear of the leaning post. In the forward seating position the first seat side provides a forward seating surface for supporting a seated occupant facing the bow and the second seat side provides a forward backrest surface for supporting the seated occupant facing the bow. In the rearward seating position the second seat side provides a rearward seating surface for supporting a seated occupant facing the stern and the first seat side provides a rearward backrest surface for supporting the seated occupant facing the stern.

Abstract: The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the treatment comprises administering at least two direct acting antiviral agents to a subject with HCV infection, wherein the treatment lasts for 12 weeks and does not include administration of either interferon or ribavirin, and said at least two direct acting antiviral agents comprise (a) Compound 1 or a pharmaceutically acceptable salt thereof and (b) Compound 2 or a pharmaceutically acceptable salt thereof.

Abstract: A catheter includes a handle and an elongate member extending from the handle. The catheter may also include steering system coupled to the handle. The steering system may be configured to deflect at least a portion of the elongate member in at least one direction. The catheter may also include a locking mechanism configured to lock the portion of the elongate member in a deflected configuration, and a lever coupled to the handle. The lever may be configured to move from a first position to a second position to engage the locking mechanism. The lever may also be configured to be separably retained at least at one of the first position or the second position to prevent movement therebetween.

Abstract: Described are various embodiments of a system and method for controlling film thickness, and a film deposition system and method using same. In one such embodiments, a vapour deposition system for spatially controlling a deposited film thickness on a substrate comprises: an emission source; a substrate holder; and a translatable shutter comprising a flux barrier disposed between said emission source and the substrate and operable to translate said flux barrier through a deposition flux according to a designated linear translation profile designated to spatially control the deposited film thickness.

Abstract: The present invention relates to immunoassays for identifying one or more types of free light chains. In particular the invention relates to a method for assaying Free Light Chains (FLCs) in a mammalian sample comprising the use of at least one avian-derived antibody (IgY). The invention also relates to a method for screening, diagnosis, monitoring or prognosis of a disease in a patient comprising conducting the assay method. The invention also relates to the use of avian-derived antibodies (IgY) in an immunoassay for assaying FLCs in a mammalian sample.

Abstract: Described are various embodiments of a system and method for controlling film thickness, and a film deposition system and method using same. In one such embodiments, a vapour deposition system for spatially controlling a deposited film thickness on a substrate comprises: an emission source; a substrate holder; and a translatable shutter comprising a flux barrier disposed between said emission source and the substrate and operable to translate said flux barrier through a deposition flux according to a designated linear translation profile designated to spatially control the deposited film thickness.

Abstract: Examples of the present disclosure relate to an apparatus comprising interface circuitry to receive memory access commands directed to a memory device, each memory access command specifying a memory address to be accessed. The apparatus comprises scheduler circuitry to store a representation of a plurality of states accessible to the memory device and, based on the representation, determine an order for the received memory access commands. The apparatus comprises dispatch circuitry to receive the received memory access commands from the scheduler circuitry and issue the received memory access commands, in the determined order, to be performed by the memory device.

Abstract: The present invention involves a brace garment arranged for enveloping at least in part a joint of a human user comprises an extensible matrix fabric, at least one low elasticity web portion having a zonal fabric different from the matrix fabric, and at least one corresponding tension member disposed to induce tension in the at least one low elasticity web portion. The one boundary between the low elasticity web portion and the matrix fabric is a continuously knitted boundary. The garment may comprise conduits knitted into the matrix fabric and the low elasticity web portion for guiding the at least one tension member. The path of the tension member spatially relates the at least one tension member to at least one natural ligament of the knee, at least one of the low elasticity web portions being disposed to apply pressure to a side of the knee.

Abstract: A catheter includes a handle and an elongate member extending from the handle. The catheter may also include steering system coupled to the handle. The steering system may be configured to deflect at least a portion of the elongate member in at least one direction. The catheter may also include a locking mechanism configured to lock the portion of the elongate member in a deflected configuration, and a lever coupled to the handle. The lever may be configured to move from a first position to a second position to engage the locking mechanism. The lever may also be configured to be separably retained at least at one of the first position or the second position to prevent movement therebetween.

Abstract: Video content enhancement methods, systems and devices are disclosed. An input video 11 is processed to generate an augmentation descriptor 4 from it, the augmentation descriptor 4 defining augmentations that enhance the content of the input video 11. An output video 14 is generated by combining the augmentations defined by the augmentation descriptor 4 with the input video 11, so that playback of the output video 14 features said augmentations. A timecoded transcript is generated from at least an audio portion of the input video 11, and the timecoded transcript is processed to generate from it a set of transcript-derived enhancements. The set of transcript-derived enhancements are added to the augmentation descriptor 4 as augmentations for enhancing the content of the input video 11.

Abstract: The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the treatment comprises administering at least two direct acting antiviral agents to a subject with HCV infection, wherein the treatment lasts for 12 weeks and does not include administration of either interferon or ribavirin, and said at least two direct acting antiviral agents comprise (a) Compound 1 or a pharmaceutically acceptable salt thereof and (b) Compound 2 or a pharmaceutically acceptable salt thereof.

Abstract: A method is provided for operating a gas turbine engine. The method includes: determining data indicative of an operation of a cooling system of the gas turbine engine during a shutdown of the gas turbine engine, following the shutdown of the gas turbine engine, or both; and modifying a startup schedule of the gas turbine engine in response to the determined data indicative of the operation of the cooling system of the gas turbine engine.

Abstract: To protect the integrity of data stored in a protected area of memory, data in the protected area of memory is retrieved in data blocks and an authentication code is associated with a memory granule contiguously comprising a first data block and a second data block. Calculation of the authentication code comprises a cryptographic calculation based on a first hash value determined from the first data block and a second hash value determined from the second data block. A hash value cache is provided to store hash values determined from data blocks retrieved from the protected area of the memory. When the first data block and its associated authentication code are retrieved from memory, a lookup for the second hash value in the hash value cache is performed, and a verification authentication code is calculated for the memory granule to which that data block belongs. The integrity of the first data block is contingent on the verification authentication code matching the retrieved authentication code.

Abstract: A catheter includes a handle and an elongate member extending from the handle. The catheter may also include steering system coupled to the handle. The steering system may be configured to deflect at least a portion of the elongate member in at least one direction. The catheter may also include a locking mechanism configured to lock the portion of the elongate member in a deflected configuration, and a lever coupled to the handle. The lever may be configured to move from a first position to a second position to engage the locking mechanism. The lever may also be configured to be separably retained at least at one of the first position or the second position to prevent movement therebetween.

Abstract: A processing system may apply a community detection process to a feature graph database to identify a plurality of communities of features, the feature graph database comprising: a plurality of objects, each associated with one of a feature or a concept, and a plurality of relationships between the plurality of objects. Next, the processing system may label a first plurality of features of the feature graph database with at least a first community label, where the first plurality of features comprises features of at least a first community of the plurality of communities. The processing system may then obtain a search associated with at least one feature of the feature graph database, where the at least one feature is a part of the at least the first plurality of features of the at least the first community, and provide the first plurality of features in response to the search.

Abstract: A processing system may obtain a request to add at least a first feature to a feature graph database, where the request comprises a first feature ontology of the first feature, and where the first feature ontology comprises: a label of the first feature and a relationship of the first feature to a concept or to another feature. The processing system may then identify whether the first feature is a duplicate of a second feature in the feature graph database based at least upon the first feature ontology and a second feature ontology of the second feature and generate an indication of whether the first feature is a duplicate in response to the identifying.

Abstract: A catheter includes a handle and an elongate member extending from the handle. The catheter may also include steering system coupled to the handle. The steering system may be configured to deflect at least a portion of the elongate member in at least one direction. The catheter may also include a locking mechanism configured to lock the portion of the elongate member in a deflected configuration, and a lever coupled to the handle. The lever may be configured to move from a first position to a second position to engage the locking mechanism. The lever may also be configured to be separably retained at least at one of the first position or the second position to prevent movement therebetween.

Abstract: A modular enclosure system and method for repair of one or more leaks in a pipe. The modular enclosure system including a first enclosure portion configured to be disposed in a mated configuration to create a first enclosure around the pipe. Each enclosure includes a first void section configured to enclose a pipe section of the pipe. Sealant grooves extend along enclosure faces of each enclosure to seal the modular enclosure system. Each enclosure includes a sealant control system having a plurality of blocking members and configured to selectively block sealant injected in the sealant grooves. Each of the blocking members are positionable between a blocking position configured to block sealant flow in at least one of the sealant grooves and a non-blocking position.

Abstract: A processing system including at least one processor may obtain a personal identifier comprising a plurality of characters and generate a first embedding of the personal identifier in accordance with an embedding model. The processing system may then identify one or more embeddings of other personal identifiers that are within a threshold distance of the first embedding and generate an alert in response to the identifying of the one or more embeddings of the other personal identifiers that are within the threshold distance.